Apple Valley Classic League Jan. 6, 2025 • Team / high game: Apple Valley Pro Shop 648 • Team / high series: Billy’s Bombers 1,889 • Women / high game: Megan Pavlik 227, Michelle Pfannenstiel 215, Penny Kramer 214 • Women / high series: Megan Pavlik 597, Michelle Pfannenstiel 593, Barb Pavlik 542 • Men / … Read more
By Thomas Kerr, CFA NASDAQ:CTSO READ THE FULL CTSO RESEARCH REPORT On January 3, 2025, CytoSorbents (NASDAQ:CTSO) reported strong preliminary 4th quarter and full year 2024 financial results which exceeded our expectations. 4th quarter product revenue (excluding grant income) is estimated to be in the range of $9.0-$9.2 million, which is approximately 22% to 25% … Read more
Hungary is often portrayed as a problem case for European integration due to frequent clashes between Viktor Orbán’s government and the EU’s institutions. Yet as András Bíró-Nagy and Gergő Medve-Bálint explain, the country’s 20 years in the EU have also seen a relatively high level of compliance with EU policies and strong support for membership … Read more
In October, OpenAI’s ChatGPT Search became available for ChatGPT Plus users. Last week, it became available to all users and was added to search in Voice Mode. And, of course, it isn’t without its flaws. The Guardian asked ChatGPT to summarize webpages that contain hidden content and, it turns out, hidden content can manipulate the … Read more
By Brad Sorensen, CFA OTC:NRXBF READ THE FULL NRXBF RESEARCH REPORT NurExone (OTC:NRXBF) is developing a product known as ExoPTEN that is designed to treat patients with acute spinal cord injuries and these numbers suggest a potential market for ExoPTEN of approximately 50,000 new cases globally per year—an enormous market potential with patients eager to … Read more
